MAZE Overview
Upcoming Projects (MAZE)
-
A Second Opinion: Reviewing Maze Therapeutics' Topline Data from the Phase 2 HORIZON Trial of MZE829 in Patients with Broad APOL1-Mediated Kidney Disease
Tickers: MAZE, VRTX, JNJ, AZN, LLY, Boehringer Ingelheim
Scheduled For: Apr 14, 2026 at 01:00 PM EDT
Executed Projects (MAZE)
-
Reviewing Maze Therapeutics' Topline Data from the Phase 2 HORIZON Trial of MZE829 in Patients with Broad APOL1-Mediated Kidney Disease
Tickers: MAZE, VRTX, AZN, LLY, JNJ, Boehringer Ingelheim
Executed On: Apr 13, 2026 at 02:00 PM EDT
Upcoming & Overdue Catalysts (MAZE)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (MAZE)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
